Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: The incidence of metabolic syndrome (MetS) is increasing, and research indicates a further increased risk of MetS in trauma-exposed individuals, which is yet to be fully understood. Therefore, this study aimed to investigate the risk of MetS in trauma-exposed inpatients compared to blood donors and the influence of putative associated psychological, biological, and behavioral risk factors for MetS.
Patients And Methods: A cross-sectional study of trauma-exposed inpatients (n = 134) compared to blood donors (n = 68) was conducted. Clinical data, blood biomarkers, and self-administered questionnaires were collected. Descriptive statistics and multivariable logistic regression, including interaction analyses, were performed to explore the odds ratio (OR) of MetS among trauma-exposed inpatients compared to blood donors as well as the interaction effects of putative risk factors.
Results: A significantly higher age- and gender adjusted OR (OR = 2.51, 95% CI 1.18-5.34) of MetS was found among trauma-exposed inpatients compared to the blood donors. Adjusted for education, cigarette smoking, symptoms of disordered eating and consumption of selected nutrients, the higher OR of MetS remained significant in the inpatients compared to the blood donors, ranging from OR = 2.27 95% CI 1.00-5.14 for symptoms of "dieting" to OR = 3.06 95% CI 1.16-8.10 for adult trauma. A significant interaction effect was documented only between group and age (OR = 1.07, 95% CI 1.01-1.13).
Conclusion: The trauma-exposed inpatients in this study had significantly higher age- and gender adjusted risk of MetS compared to the blood donors, and psychological and behavioral lifestyle factors appeared to increase the risk of MetS.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12333625 | PMC |
| http://dx.doi.org/10.2147/DMSO.S536015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Increased serologic reactivity with automated CMIA testing and its implications for deceased donor eligibility determination in the United States.
Cell Tissue Bank
September 2025
Eurofins Donor & Product Testing, LLC, Centennial, CO, USA.
In the United States, the use of Food & Drug Administration (FDA)-licensed, approved, or cleared tests is required for infectious disease screening and determining the eligibility of deceased donors for all Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). With the discontinuation of two manual enzyme-linked immunoassay (EIA) tests, automated Chemiluminescent Microparticle Immunoassay (CMIA) technology was introduced as the primary alternative. This study compares serologic reactivity rates between manual EIA and automated CMIA methods.
View Article and Find Full Text PDFBlood Donation Knowledge, Attitudes, and Practices Amid Instability: A Biphasic Cross-Sectional Study in West Bank, Palestine (2022 vs 2025).
SAGE Open Nurs
September 2025
Faculty of Health Professions, Al-Quds University, Abu Dies, Palestine.
Introduction: Blood supply shortages remain a pressing global health issue, particularly in resource-limited regions. The West Bank region in Palestine, characterized by frequent conflicts and instability, faces additional challenges due to its fragile healthcare system, where a substantial proportion of blood donations still relies on family-replacement donors rather than voluntary donations.
Objective: This study examines changes in knowledge, attitudes, and practices (KAP) related to blood donation among Palestinians from 2022 to 2025, aiming to guide strategies for a sustainable voluntary donation system.
Prevalence of human T-cell lymphotropic virus type 1 or 2 among blood donors screened at the New Zealand Blood Service: An observational study, 2001-2024.
Prev Med Rep
October 2025
Planning Funding and Outcomes, Te Whatu Ora Health, New Zealand.
Objective: To investigate prevalence of Human T-cell Lymphotropic Virus type 1 or 2 (HTLV-1/2) using the New Zealand Blood Service (NZBS) data, to inform whether further HTLV-1/2 prevalence study may be required, in the context of drivers of the inequities in lung cancer for Māori (the Indigenous population).
Methods: This observational cross-sectional study used the NZBS data of all blood donors nationwide (01/01/2001-30/06/2024). Prevalence overall and by ethnicity was calculated as the number of confirmed HTLV-1/2 positive cases per 10,000 donors.
Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches.
Front Pharmacol
August 2025
Department of Pharmacy, Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh, Malaysia.
Sickle cell disease (SCD) is an inherited blood disorder marked by the production of abnormal hemoglobin, leading to the distortion-or sickling-of red blood cells. The SCD arises from a single-point mutation that substitutes glutamic acid with valine at the sixth codon of the β-globin chain in hemoglobin. This substitution promotes deoxyhemoglobin aggregation, elevating red blood cell stiffness, and triggering vaso-occlusive and hemolytic repercussions.
View Article and Find Full Text PDFAntibodies against integrin αvβ6 have high diagnostic accuracy for ulcerative colitis.
Front Immunol
September 2025
Medicine 1 Unit, Ca' Foncello University Hospital, Treviso, Italy.
Background: Anti-integrin αvβ6 IgG autoantibodies showed good sensitivity and optimal specificity in ulcerative colitis (UC) compared to controls. We aim at confirming the diagnostic accuracy of anti-integrin αvβ6 autoantibodies in an Italian multicentric cohort.
Methods: This observational multicentric study included adult and pediatric patients with inflammatory bowel disease and controls.